Very High Prenatal PFAS Exposure Linked to Childhood Asthma

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on April 10, 2026.

via HealthDay

FRIDAY, April 10, 2026 -- Very high prenatal per- and polyfluoroalkyl substance (PFAS) exposure is associated with an increased incidence of childhood asthma, according to a study published online April 9 in PLOS Medicine.

Annelise J. Blomberg, Sc.D., from Lund University in Sweden, and colleagues estimated associations between prenatal PFAS exposure and childhood incidence of asthma and wheeze in Blekinge County, Sweden, where a subset of residents was exposed to PFAS from drinking water contaminated by aqueous film-forming foam (AFFF). A register-based open cohort of 11,488 children born in Blekinge County between 2006 and 2013 was constructed; they were followed from birth until age 12 or Dec. 31, 2022.

During follow-up, 18 percent of children were diagnosed with wheeze and 17 percent were diagnosed with asthma. The researchers found an association for very high prenatal PFAS exposure with asthma incidence (hazard ratio, 1.44), while no associations were seen for high or intermediate exposure or for wheeze. The estimated cumulative incidence of asthma was 16.1 percent in the background-exposed group and 26.7 percent in the very highly exposed group in the Rubin causal model analysis.

"Our findings indicate that children with very high prenatal PFAS exposure from AFFF-contaminated drinking water experienced greater asthma incidence than those with background exposure," the authors write. "These findings likely have limited generalizability to populations with only background-level exposures or different PFAS mixtures, as exposure-response relationships remain uncertain and individual compounds vary in toxicity."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-11 08:56

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords